Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Apr 2016 07:00

RNS Number : 2811U
Scancell Holdings Plc
06 April 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Scancell Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Calculus Capital Limited

4. Full name of shareholder(s)  (if different from 3.):iv

Reyker Nominees/Investec Wealth and Investment

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

5 April 2016

6. Date on which issuer notified:

5 April 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

16%, 17%, 18%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

ISIN: GB00B63D3314

35,085,706

35,085,706

49,203,353

49,203,353

18.8%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

49,203,353

18.8%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Calculus Capital Limited

15. Contact telephone number:

0207 493 4940

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFLTSEIEIIR
Date   Source Headline
5th Oct 20214:22 pmRNSFirst subject dosed in COVIDITY clinical trial
9th Sep 20214:31 pmRNSPDMR dealing
26th Aug 20217:00 amRNSModi-1 Phase I/II CTA approved by MHRA
17th Aug 20217:00 amRNSScancell selects PharmaJet’s Needle-free Systems
30th Jul 20219:52 amRNSDirector Dealing
29th Jul 20217:00 amRNSCOVIDITY Phase 1 trial application in SA approved
28th Jul 20215:00 pmRNSLindy Durrant appointed CEO of Scancell
22nd Jun 20217:00 amRNSCOVIDITY trial planned in South Africa and UK
15th Jun 20217:00 amRNSAppointment of Joint Broker
8th Jun 20214:41 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
7th Jun 20218:49 amRNSDirector Dealing
30th Apr 202110:48 amRNSDirector Dealing
10th Mar 20219:58 amRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:00 pmRNSDirector Dealing
19th Feb 20217:00 amRNSDirector Dealing
17th Feb 20212:04 pmRNSDirector Dealing
16th Feb 20213:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Feb 20213:36 pmRNSStatement regarding share price movement
15th Feb 202111:05 amRNSSecond Price Monitoring Extn
15th Feb 202111:00 amRNSPrice Monitoring Extension
15th Feb 20219:05 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSUpdate on SCIB2 clinical development partnership
29th Jan 20217:00 amRNSInterim Results for the 6 months ended 31 Oct 2020
30th Dec 20202:00 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
18th Dec 20202:05 pmRNSSecond Price Monitoring Extn
18th Dec 20202:00 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSCOVID-19 vaccine candidate selected
15th Dec 20203:45 pmRNSDirector Dealing
14th Dec 20201:03 pmRNSDirector Dealing
25th Nov 202011:26 amRNSDirector Dealing
17th Nov 20202:34 pmRNSResults of Annual General Meeting
17th Nov 202012:00 pmRNSAppointment of CMO and Medical Director
13th Nov 202012:36 pmRNSDirector Dealing
10th Nov 20202:44 pmRNSDirector Dealing
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
6th Nov 202011:49 amRNSHolding(s) in Company
5th Nov 202010:51 amRNSResult of Adjourned General Meeting
3rd Nov 20208:33 amRNSHolding(s) in Company
2nd Nov 20205:00 pmRNSConvertible Loan Notes & Total Voting Rights
29th Oct 202010:15 amRNSResult of Open Offer and Adjournment of GM
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.